QSS
XENE icon

Quantitative Systematic Strategies’s Xenon Pharmaceuticals XENE Stock Holding History

Quantitative Systematic Strategies’s Portfolio XENE Stock Details XENE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-12,343
Closed -$230K – 384
2021
Q2 		$230K Sell
12,343
-12,865
-51% -$237K 0.08% 396
2021
Q1 		$451K Sell
25,208
-4,076
-14% -$69.1K 0.07% 390
2020
Q4 		$450K Buy
29,284
+17,330
+145% +$203K 0.06% 410
2020
Q3 		$132K Buy
11,954
+278
+2% +$3.27K 0.02% 554
2020
Q2 		$146K Buy
+11,676
New +$149K 0.03% 539

Other funds holding XENE

ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return

Quantitative Systematic Strategies's XENE Position: Q3 2021 in Review

Quantitative Systematic Strategies sold out of Xenon Pharmaceuticals (XENE) in Q3 2021, closing a stake of 12,343 shares — an estimated $230K sold.

Quantitative Systematic Strategies first reported a position in XENE in Q2 2020 and held it in 5 quarters. The position peaked at $451K in Q1 2021. 118 funds tracked by Wall St. Rank hold XENE as of Q3 2021.

  • Quantitative Systematic Strategies reported no remaining Xenon Pharmaceuticals position as of Q3 2021 after selling out during the quarter.
  • Quantitative Systematic Strategies sold 12,343 Xenon Pharmaceuticals shares in Q3 2021, an estimated $230K.
  • Quantitative Systematic Strategies first reported a position in Xenon Pharmaceuticals in Q2 2020 and held it in 5 quarters.
  • Quantitative Systematic Strategies's Xenon Pharmaceuticals position peaked at $451K in Q1 2021.
  • 118 funds tracked by Wall St. Rank held Xenon Pharmaceuticals as of Q3 2021.

Based on Quantitative Systematic Strategies's 13F filing for Q3 2021, filed 16 Nov 2021.